Annual corporate governance report | Grifols

Company

Content: company-destacado-1

We improve the health and well-being of patients around the world.

Content: company-destacado-2

Four business divisions united by a shared commitment to quality, safety and on-going innovation.

Commitment

Content: commitment-destacado-1

Patients inspire the work we do every day.

Content: commitment-destacado-2

We support the development of the scientific community and its research efforts.

Innovation

Content: innovation-destacado-1

Take a look at the portfolio of products and therapies currently in development.

Content: innovation-destacado-2

AMBAR, an ambitious research project on Alzheimer's.

AMBAR

Content: ambar-destacado-1

The AMBAR study

Take a look at the information about the AMBAR study

Content: ambar-destacado-2

The AMBAR results

The AMBAR trial results

Team

Team

Content: team-destacado-1

We strive to cultivate a friendly, diverse and inclusive work environment.

Content: team-destacado-2

Grifols is becoming increasingly global. A diverse team will remain a key component to our future success.

Products and services

ANNUAL CORPORATE GOVERNANCE REPORT

Annual corporate governance report

Content: footer-organization-info

The information contained on the Grifols worldwide website is not applicable to all countries. For specific information on the products and services available in your country, please select your country from the list included in the corresponding section. The purpose of this website is to provide information about Grifols' products and services, and it is not intended for, nor may it be construed to, promoting any products in countries in which they are not approved.